IVERIC bio, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2017 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
IVERIC bio, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2017 to Q1 2023.
  • IVERIC bio, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $2.59M, a 24.5% increase year-over-year.
  • IVERIC bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $429M, a 57.5% increase from 2021.
  • IVERIC bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $272M, a 80.9% increase from 2020.
  • IVERIC bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $151M, a 252% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $2.59M +$509K +24.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q1 2022 $2.08M +$1.95M +1512% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 $129K -$50K -27.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 $179K +$138K +337% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 $41K +$14K +51.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $27K -$4K -12.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2017 $31K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.